ADXS  looks to be the next GHSI type big run candidate. They have a major pipeline update in the coming days.  “We look forward to providing a more detailed pipeline update next month with important details relevant to the advancement of our innovative immunotherapy clinical programs.” ADXS has $41.8m cash  which is well over 50c...